Exporter
Liste modèle des médicaments essentiels
effacer
Trouvé 352 recommandations pour 186 médicaments et 10 équivalents thérapeutiques
Les médicaments retirés et les demandes rejetées ne sont pas indiqués. Les afficher.
-
Medicines for COVID-19 Informations générales
SectionMedicines for COVID-19- Refer to WHO living guidelines
Indications -
Abacavir Informations générales
SectionAntiretrovirals > Nucleoside/Nucleotide reverse transcriptase inhibitors- Oral > Solid: 300 mg tablet (as sulfate)
-
Abacavir + lamivudine Informations générales
SectionFixed-dose combinations of antiretrovirals- Oral > Solid: 120 mg (as sulfate) + 60 mg tablet (dispersible, scored)
-
Aciclovir Informations générales
SectionAntiherpes medicines- Parenteral > General injections > IV: 250 mg in vial powder for injection (as sodium salt)
- Oral > Liquid: 200 mg per 5 mL
- Oral > Solid: 200 mg tablet
Indications -
Albendazole Informations générales
SectionIntestinal anthelminthics- Oral > Solid > tablet: 400 mg (chewable, scored)
- Oral > Solid > tablet: 400 mg (chewable, scored))
SectionCysticidal medicines- Oral > Solid > tablet: 400 mg (chewable, scored); 200 mg (chewable)
SectionAntifilarials- Oral > Solid > tablet: 400 mg (chewable, scored)
Indications -
Amikacin Informations générales
SectionAccess group antibiotics- Parenteral > General injections > unspecified: 250 mg per mL in 2 mL vial (as sulfate)
IndicationsPremier choix
co-prescrite avec cefotaxime Acute pyelonephritis (severe) co-prescrite avec ceftriaxone Acute pyelonephritis (severe)Second choix
co-prescrite avec cloxacillin Sepsis without septic shockSectionAntituberculosis medicines- Parenteral > General injections > unspecified: 250 mg per mL in 2 mL vial (as sulfate)
Indications -
Amodiaquine Informations générales
SectionAntimalarial medicines > For curative treatment- Oral > Solid: 153 mg (as hydrochloride); 200 mg (as hydrochloride)
-
Amodiaquine + sulfadoxine + pyrimethamine Informations générales
SectionAntimalarial medicines > For chemoprevention- Oral > Solid: 76.5 mg (as hydrochloride) [3] + 250 mg + 12.5 mg [1] dispersible tablets in co-package; 153 mg (as hydrochloride) [3] + 500 mg + 25 mg [1] dispersible tablets in co-package
Indications -
Amoxicillin Informations générales
SectionAccess group antibiotics- Oral > Liquid: 125 mg per 5 mL (as trihydrate) powder for oral liquid; 250 mg per 5 mL (as trihydrate) powder for oral liquid
- Oral > Solid: 250 mg (as trihydrate); 500 mg (as trihydrate)
- Parenteral > General injections > unspecified: 250 mg in vial (as sodium) powder for injection; 500 mg in vial (as sodium) powder for injection; 1 g in vial (as sodium) powder for injection
IndicationsPremier choix
Chronic obstructive pulmonary disease with acute exacerbation co-prescrite avec gentamicin Sepsis without septic shock -
Amoxicillin + clavulanic acid Informations générales
SectionAccess group antibiotics- Parenteral > General injections > IV: 500 mg (as sodium salt) + 100 mg (as potassium salt) powder for injection; 1000 mg (as sodium salt) + 200 mg (as potassium salt) powder for injection
- Oral > Solid: 500 mg (as trihydrate) + 125 mg (as potassium salt)
- Oral > Liquid: 125 mg (as trihydrate) + 31.25 mg (as potassium salt) powder for oral liquid; 250 mg (as trihydrate) + 62.5 mg (as potassium salt) powder for oral liquid
- Oral > Solid: 500 mg (as trihydrate) + 125 mg (as potassium salt); 875 mg (as trihydrate) + 125 mg (as potassium salt)
- Oral > Solid > dispersible tablet: 200 mg (as trihydrate) + 28.5 mg (as potassium salt); 250 mg (as trihydrate) + 62.5 mg (as potassium salt)
IndicationsSectionAntituberculosis medicines- Oral > Liquid: 250 mg (as trihydrate) + 62.5 mg per 5 mL (as potassium salt) powder for oral liquid
- Oral > Solid: 500 mg (as trihydrate) + 125 mg (as potassium salt)
Indications -
Amphotericin B Informations générales
SectionAntifungal medicines- Parenteral > General injections > IV: 50 mg in vial powder for injection (liposomal complex); 50 mg in vial powder for injection (as sodium deoxycholate)
SectionAntileishmaniasis medicines- Parenteral > General injections > IV: 50 mg in vial powder for injection (liposomal complex); 50 mg in vial powder for injection (as sodium deoxycholate)
Indications -
Ampicillin Informations générales
SectionAccess group antibiotics- Parenteral > General injections > unspecified: 500 mg in vial (as sodium salt) powder for injection; 1 g in vial (as sodium salt) powder for injection
IndicationsPremier choix
co-prescrite avec gentamicin Peritoneal abscess (severe) co-prescrite avec gentamicin Sepsis without septic shock co-prescrite avec gentamicin Peritoneal abscess (mild-moderate) co-prescrite avec gentamicin Peritonitis (severe) co-prescrite avec gentamicin Acute malnutrition in infants, children or adolescents (complicated) [children] co-prescrite avec gentamicin Peritonitis (mild-moderate) co-prescrite avec gentamicin Bacterial pneumonia (Community-acquired pneumonia - severe) [children]Second choix
Bacterial meningitis -
Anidulafungin Informations générales
SectionAntifungal medicinesIndicationsTherapeutic equivalent to micafungin pour Systemic or invasive candidosis -
Ansuvimab Informations générales
SectionMedicines for Ebola virus disease- Parenteral > General injections > IV: 400 mg powder for injection
Indications -
Artemether Informations générales
SectionAntimalarial medicines > For curative treatment- Parenteral > General injections > IM: 80 mg per mL in 1 mL ampoule (oily injection)
-
Artemether + lumefantrine Informations générales
SectionAntimalarial medicines > For curative treatment- Oral > Solid: 20 mg + 120 mg tablet; 20 mg + 120 mg dispersible tablet
-
Artesunate Informations générales
SectionAntimalarial medicines > For curative treatment- Parenteral > General injections > IV: 60 mg in ampoule containing anhydrous artesunic acid with a separate ampoule of 5% sodium bicarbonate solution
- Oral > Solid: 50 mg tablet
- Local > Rectal > Other: 50 mg capsules; 200 mg capsules; 100 mg capsules
-
Artesunate + amodiaquine Informations générales
SectionAntimalarial medicines > For curative treatment- Oral > Solid: 25 mg + 67.5 mg tablet; 50 mg + 135 mg tablet; 100 mg + 270 mg tablet
-
Artesunate + mefloquine Informations générales
SectionAntimalarial medicines > For curative treatment- Oral > Solid: 25 mg + 55 mg tablet; 100 mg + 220 mg tablet
-
Artesunate + pyronaridine tetraphosphate Informations générales
SectionAntimalarial medicines > For curative treatment- Oral > Solid: 60 mg + 180 mg tablet; 20 mg + 60 mg granules
-
Atazanavir + ritonavir Informations générales
SectionAntiretrovirals > Protease inhibitors- Oral > Solid: 300 mg (as sulfate) + 100 mg tablet (heat stable)
-
Atoltivimab + maftivimab + odesivimab Informations générales
SectionMedicines for Ebola virus disease- Parenteral > General injections > IV: 241.7 mg + 241.7 mg + 241.7 mg in 14.5 mL vial
Indications -
Azithromycin Informations générales
SectionWatch group antibiotics- Oral > Liquid: 200 mg per 5 mL oral liquid
- Oral > Solid: 250 mg (anhydrous) capsule; 500 mg (anhydrous) capsule
IndicationsPremier choix
co-prescrite avec ceftriaxone Gonococcal infectionSecond choix
co-prescrite avec cefixime Gonococcal infection -
Bedaquiline Informations générales
SectionAntituberculosis medicines- Oral > Solid: 100 mg tablet; 20 mg tablet
Indications -
Benzathine benzylpenicillin Informations générales
SectionAccess group antibiotics- Parenteral > General injections > IM: 900 mg in vial benzylpenicillin powder for injection (= 1.2 million IU); 1.44 g in vial benzylpenicillin powder for injection (= 2.4 million IU)
-
Benznidazole Informations générales
SectionAmerican trypanosomiasis- Oral > Solid > tablet: 100 mg (scored); 50 mg (scored); 12.5 mg
Indications -
Benzylpenicillin Informations générales
SectionAccess group antibiotics- Parenteral > General injections > unspecified: 600 mg in vial powder for injection (=1 million IU as sodium or potassium salt); 3 g in vial powder for injection (=5 million IU as sodium or potassium salt)
IndicationsPremier choix
Congenital syphilis [children] Syphilis co-prescrite avec gentamicin Sepsis without septic shock co-prescrite avec gentamicin Acute malnutrition in infants, children or adolescents (complicated) [children] co-prescrite avec gentamicin Bacterial pneumonia (Community-acquired pneumonia - severe) [children]Second choix
Bacterial meningitis -
Caspofungin Informations générales
SectionAntifungal medicinesIndicationsTherapeutic equivalent to micafungin pour Systemic or invasive candidosis -
Cefalexin Informations générales
SectionAccess group antibiotics- Oral > Liquid: 125 mg per 5 mL (anhydrous) powder for oral liquid; 250 mg per 5 mL (anhydrous) powder for oral liquid
- Oral > Solid: 250 mg (as monohydrate); 500 mg (as monohydrate)
-
Cefazolin Informations générales
SectionAccess group antibiotics- Parenteral > General injections > unspecified: 1 g in vial (as sodium salt) powder for injection
IndicationsPremier choix
Other specified prophylactic measures co-prescrite avec metronidazole Other specified prophylactic measures -
Cefixime Informations générales
SectionWatch group antibiotics- Oral > Liquid: 100 mg per 5 mL powder for oral liquid
- Oral > Solid: 200 mg (as trihydrate); 400 mg (as trihydrate)
IndicationsSecond choix
Infectious gastroenteritis or colitis without specification of infectious agent co-prescrite avec azithromycin Gonococcal infection -
Ceftazidime Informations générales
SectionWatch group antibiotics- Parenteral > General injections > unspecified: 250 mg in vial (as pentahydrate) powder for injection; 1 g in vial (as pentahydrate) powder for injection
-
Ceftazidime + avibactam Informations générales
SectionReserve group antibiotics- Parenteral > General injections > IV: 2 g in vial + 0.5 g in vial powder for injection
-
Ceftolozane + tazobactam Informations générales
SectionReserve group antibiotics- Parenteral > General injections > IV: 1 g + 0.5 g powder for injection
Indications -
Ceftriaxone Informations générales
SectionWatch group antibiotics- Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)
-
Cefuroxime Informations générales
SectionWatch group antibiotics- Parenteral > General injections > IV: 250 mg in vial (as sodium salt) powder for injection; 750 mg in vial (as sodium salt) powder for injection; 1.5 g in vial (as sodium salt) powder for injection
-
Chloroquine Informations générales
SectionAntimalarial medicines > For curative treatment- Oral > Liquid: 50 mg per 5 mL syrup (as phosphate or sulfate)
- Oral > Solid: 150 mg tablet (as phosphate or sulfate); 100 mg tablet (as phosphate or sulfate)
IndicationsSectionAntimalarial medicines > For chemoprevention- Oral > Liquid: 50 mg per 5 mL syrup (as phosphate or sulfate)
- Oral > Solid: 150 mg tablet (as phosphate or sulfate)
-
Ciprofloxacin Informations générales
SectionWatch group antibiotics- Oral > Solid: 250 mg (as hydrochloride); 500 mg (as hydrochloride)
-
Clofazimine Informations générales
SectionAntituberculosis medicines- Oral > Solid: 100 mg; 50 mg
IndicationsSectionAntileprosy medicines- Oral > Solid: 100 mg; 50 mg
Indications -
Clotrimazole Informations générales
SectionAntifungal medicines- Local > Topical > Other: 1% vaginal cream; 10% vaginal cream; 100 mg vaginal tablet; 500 mg vaginal tablet
Indications -
Cycloserine Informations générales
SectionAntituberculosis medicines- Oral > Solid: 250 mg; 125 mg
Indications -
Daclatasvir Informations générales
SectionMedicines for hepatitis C > Pangenotypic direct-acting antiviral combinations- Oral > Solid: 30 mg tablet (as hydrochloride); 60 mg tablet (as hydrochloride)
Indications -
Daclatasvir + sofosbuvir Informations générales
SectionMedicines for hepatitis C > Pangenotypic direct-acting antiviral combinations- Oral > Solid: 60 mg + 400 mg
Indications -
Dapsone Informations générales
SectionAntileprosy medicines- Oral > Solid: 100 mg tablet; 50 mg tablet; 25 mg tablet
Indications -
Darunavir Informations générales
SectionAntiretrovirals > Protease inhibitors- Oral > Solid: 75 mg; 400 mg; 600 mg; 800 mg
-
Delamanid Informations générales
SectionAntituberculosis medicines- Oral > Solid: 50 mg tablet; 25 mg tablet (dispersible)
Indications -
Diethylcarbamazine Informations générales
SectionAntifilarials- Oral > Solid: 50 mg tablet (dihydrogen citrate); 100 mg tablet (dihydrogen citrate)
Indications -
Dihydroartemisinin + piperaquine phosphate Informations générales
SectionAntimalarial medicines > For curative treatment- Oral > Solid: 40 mg + 320 mg tablet; 20 mg + 160 mg tablet
-
Diloxanide Informations générales
SectionAntiamoebic and antigiardiasis medicines- Oral > Solid: 500 mg (furoate)
Indications -
Dolutegravir Informations générales
SectionAntiretrovirals > Integrase inhibitors- Oral > Solid: 50 mg tablet; 10 mg tablet (dispersible, scored)
-
Dolutegravir + lamivudine + tenofovir Informations générales
SectionFixed-dose combinations of antiretrovirals- Oral > Solid: 50 mg + 300 mg + 300 mg (tenofovir disoproxil fumarate equivalent to 245 mg tenofovir disoproxil)
-
Doxycycline Informations générales
SectionAccess group antibiotics- Oral > Solid: 100 mg (as hyclate)
- Parenteral > General injections > unspecified: 100 mg in vial powder for injection
SectionAntimalarial medicines > For curative treatment- Oral > Solid: 100 mg (hydrochloride or hyclate); 100 mg dispersible tablet (as monohydrate)
IndicationsSectionAntimalarial medicines > For chemoprevention- Oral > Solid: 100 mg (hydrochloride or hyclate)
Indications -
Efavirenz Informations générales
SectionAntiretrovirals > Non-nucleoside reverse transcriptase inhibitors- Oral > Solid: 600 mg tablet
-
Efavirenz + emtricitabine + tenofovir Informations générales
SectionFixed-dose combinations of antiretrovirals- Oral > Solid: 600 mg + 200 mg + 300 mg (tenofovir disoproxil fumarate equivalent to 245 mg tenofovir disoproxil)
-
Efavirenz + lamivudine + tenofovir Informations générales
SectionFixed-dose combinations of antiretrovirals- Oral > Solid: 400 mg + 300 mg + 300 mg (tenofovir disoproxil fumarate, equivalent to 245 mg tenofovir disoproxil)
IndicationsHuman immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified Therapeutic equivalent to efavirenz + emtricitabine + tenofovir pour Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified -
Eflornithine Informations générales
SectionMedicines for the treatment of 2nd stage African trypanosomiasis- Parenteral > General injections > IV: 200 mg per mL in 50 mL bottle (hydrochloride)
Indications -
Emtricitabine + tenofovir Informations générales
SectionFixed-dose combinations of antiretrovirals- Oral > Solid: 200 mg + 300 mg (tenofovir disoproxil fumarate equivalent to 245 mg tenofovir disoproxil)
-
Entecavir Informations générales
SectionMedicines for hepatitis B > Nucleoside/Nucleotide reverse transcriptase inhibitors- Oral > Liquid: 0.05 mg per mL
- Oral > Solid: 0.5 mg; 1 mg
Indications -
Ethambutol Informations générales
SectionAntituberculosis medicines- Oral > Solid: 100 mg (hydrochloride); 400 mg (hydrochloride); 100 mg tablet (dispersible)
Indications -
Ethambutol + isoniazid + pyrazinamide + rifampicin Informations générales
SectionAntituberculosis medicines- Oral > Solid: 275 mg + 75 mg + 400 mg + 150 mg tablet
Indications -
Ethambutol + isoniazid + rifampicin Informations générales
SectionAntituberculosis medicines- Oral > Solid: 275 mg + 75 mg + 150 mg tablet
Indications -
Ethionamide Informations générales
SectionAntituberculosis medicines- Oral > Solid: 250 mg tablet; 125 mg tablet (dispersible)
-
Fexinidazole Informations générales
SectionMedicines for the treatment of 1st stage African trypanosomiasis- Oral > Solid: 600 mg
IndicationsSectionMedicines for the treatment of 2nd stage African trypanosomiasis- Oral > Solid: 600 mg
Indications -
Fluconazole Informations générales
SectionAntifungal medicines- Parenteral > General injections > IV: 2 mg per mL in vial
- Oral > Liquid: 50 mg per 5 mL; 50 mg per 5 mL powder for oral liquid
- Oral > Solid > capsule: 50 mg
Indications -
Flucytosine Informations générales
SectionAntifungal medicines- Parenteral > General injections > IV: 2.5 g per 250 mL infusion
- Oral > Solid: 250 mg capsule
Indications -
Fosfomycin (injection) Informations générales
SectionReserve group antibiotics- Parenteral > General injections > IV: 2 g in vial (as sodium) powder for injection; 4 g in vial (as sodium) powder for injection
-
Gentamicin Informations générales
SectionAccess group antibiotics- Parenteral > General injections > unspecified: 10 mg per mL in 2 mL vial (as sulfate); 40 mg per mL in 2 mL vial (as sulfate)
IndicationsPremier choix
Neonatal meningitis co-prescrite avec amoxicillin Bacterial pneumonia (Community-acquired pneumonia - severe) [children] co-prescrite avec amoxicillin Sepsis without septic shock co-prescrite avec ampicillin Acute malnutrition in infants, children or adolescents (complicated) [children] co-prescrite avec ampicillin Peritonitis (mild-moderate) co-prescrite avec ampicillin Peritonitis (severe) co-prescrite avec ampicillin Peritoneal abscess (severe) co-prescrite avec ampicillin Sepsis without septic shock co-prescrite avec ampicillin Bacterial pneumonia (Community-acquired pneumonia - severe) [children] co-prescrite avec ampicillin Peritoneal abscess (mild-moderate) co-prescrite avec benzylpenicillin Acute malnutrition in infants, children or adolescents (complicated) [children] co-prescrite avec benzylpenicillin Sepsis without septic shock co-prescrite avec benzylpenicillin Bacterial pneumonia (Community-acquired pneumonia - severe) [children] -
Glecaprevir + pibrentasvir Informations générales
SectionMedicines for hepatitis C > Pangenotypic direct-acting antiviral combinations- Oral > Solid: 100 mg + 40 mg tablet; 50 mg + 20 mg granules
Indications -
Griseofulvin Informations générales
SectionAntifungal medicines- Oral > Liquid: 125 mg per 5 mL
- Oral > Solid: 125 mg; 250 mg
Indications -
Imipenem + cilastatin Informations générales
SectionAntituberculosis medicinesIndicationsTherapeutic equivalent to meropenem pour Multi-drug resistant Mycobacterium tuberculosisSectionWatch group antibioticsIndicationsSecond choix
Therapeutic equivalent to meropenem pour Neutropenia (high-risk) Therapeutic equivalent to meropenem pour Peritoneal abscess (severe) Therapeutic equivalent to meropenem pour Peritonitis (severe) -
Isoniazid Informations générales
SectionAntituberculosis medicines- Oral > Solid: 100 mg tablet; 100 mg tablet (dispersible); 300 mg tablet
Indications -
Isoniazid + pyrazinamide + rifampicin Informations générales
SectionAntituberculosis medicines- Oral > Solid: 50 mg + 150 mg + 75 mg tablet (dispersible)
Indications -
Isoniazid + pyridoxine + sulfamethoxazole + trimethoprim Informations générales
SectionMedicines for prevention of HIV-related opportunistic infections- Oral > Solid: 300 mg + 25 mg + 800 mg + 160 mg tablet (scored)
Indications -
Isoniazid + rifampicin Informations générales
SectionAntituberculosis medicines- Oral > Solid: 50 mg + 75 mg tablet (dispersible); 75 mg + 150 mg tablet; 150 mg + 300 mg tablet
Indications -
Isoniazid + rifapentine Informations générales
SectionAntituberculosis medicines- Oral > Solid: 300 mg + 300 mg tablet (scored)
Indications -
Itraconazole Informations générales
SectionAntifungal medicines- Oral > Liquid: 10 mg per mL
- Oral > Solid: 100 mg
-
Ivermectin Informations générales
SectionIntestinal anthelminthics- Oral > Solid > tablet: 3 mg
SectionAntifilarials- Oral > Solid > tablet: 3 mg
IndicationsSectionMedicines for ectoparasitic infections- Oral > Solid > tablet: 3 mg
Indications -
Lamivudine Informations générales
SectionAntiretrovirals > Nucleoside/Nucleotide reverse transcriptase inhibitors- Oral > Liquid: 50 mg per 5 mL
- Oral > Solid: 150 mg tablet
-
Lamivudine + tenofovir Informations générales
SectionFixed-dose combinations of antiretroviralsIndicationsTherapeutic equivalent to emtricitabine + tenofovir pour Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified Therapeutic equivalent to emtricitabine + tenofovir pour Contact with or exposure to human immunodeficiency virus -
Lamivudine + zidovudine Informations générales
SectionFixed-dose combinations of antiretrovirals- Oral > Solid: 30 mg + 60 mg Tablet; 150 mg + 300 mg Tablet
-
Ledipasvir + sofosbuvir Informations générales
SectionMedicines for hepatitis C > Non-pangenotypic direct-acting antiviral combinations- Oral > Solid: 90 mg + 400 mg tablet
Indications -
Levamisole Informations générales
SectionIntestinal anthelminthics- Oral > Solid > tablet: 50 mg (as hydrochloride); 150 mg (as hydrochloride)
Indications -
Levofloxacin Informations générales
SectionAntituberculosis medicines- Oral > Solid: 250 mg tablet; 500 mg tablet; 750 mg tablet; 100 mg tablet (dispersible)
Indications -
Linezolid Informations générales
SectionAntituberculosis medicines- Oral > Solid: 600 mg tablet; 150 mg tablet (dispersible)
Indications -
Lopinavir + ritonavir Informations générales
SectionAntiretrovirals > Protease inhibitors- Oral > Solid: 100 mg + 25 mg tablet (heat-stable); 200 mg + 50 mg tablet (heat-stable); 40 mg + 10 mg
-
Mebendazole Informations générales
SectionIntestinal anthelminthics- Oral > Solid > tablet: 100 mg (chewable); 500 mg (chewable)
IndicationsSectionCysticidal medicines- Oral > Solid > tablet: 500 mg (chewable); 100 mg (chewable)
Indications -
Mefloquine Informations générales
SectionAntimalarial medicines > For curative treatment- Oral > Solid: 250 mg tablet (hydrochloride)
SectionAntimalarial medicines > For chemoprevention- Oral > Solid: 250 mg tablet (hydrochloride)
Indications -
Meglumine antimoniate Informations générales
SectionAntileishmaniasis medicines- Parenteral > General injections > IM: 1.5 g per 5 mL in 5 mL ampoule
-
Melarsoprol Informations générales
SectionMedicines for the treatment of 2nd stage African trypanosomiasis- Parenteral > General injections > IV: 3.6% in 5 mL ampoule solution (180 mg of active compound)
Indications -
Meropenem Informations générales
SectionWatch group antibiotics- Parenteral > General injections > IV: 500 mg in vial (as trihydrate) powder for injection; 1 g in vial (as trihydrate) powder for injection
IndicationsSectionAntituberculosis medicines- Parenteral > General injections > IV: 500 mg in vial (as trihydrate) powder for injection; 1 g in vial (as trihydrate) powder for injection
Indications -
Meropenem + vaborbactam Informations générales
SectionReserve group antibiotics- Parenteral > General injections > IV: 1 g in vial + 1 g in vial powder for injection
-
Metronidazole Informations générales
SectionAccess group antibiotics- Oral > Liquid: 200 mg per 5 mL (as benzoate)
- Oral > Solid: 200 to 500 mg tablet
- Local > Rectal > Suppository: 500 mg suppository; 1 g suppository
- Parenteral > General injections > unspecified: 500 mg per 100 mL in vial Injection
IndicationsPremier choix
co-prescrite avec cefazolin Other specified prophylactic measures co-prescrite avec cefotaxime Peritoneal abscess (severe) co-prescrite avec cefotaxime Peritonitis (mild-moderate) co-prescrite avec cefotaxime Peritoneal abscess (mild-moderate) co-prescrite avec cefotaxime Peritonitis (severe) co-prescrite avec ceftriaxone Peritoneal abscess (severe) co-prescrite avec ceftriaxone Peritoneal abscess (mild-moderate) co-prescrite avec ceftriaxone Peritonitis (mild-moderate) co-prescrite avec ceftriaxone Peritonitis (severe)Second choix
co-prescrite avec ciprofloxacin Peritoneal abscess (mild-moderate) co-prescrite avec ciprofloxacin Peritonitis (mild-moderate)SectionAntiamoebic and antigiardiasis medicines- Oral > Liquid: 200 mg per 5 mL (as benzoate)
- Parenteral > General injections > unspecified: 500 mg in 100 mL vial
- Oral > Solid > tablet: 200 mg; 250 mg; 400 mg; 500 mg
Indications -
Micafungin Informations générales
SectionAntifungal medicines- Parenteral > General injections > IV: 50 mg in vial (as sodium) powder for injection; 100 mg in vial (as sodium) powder for injection
Indications -
Miltefosine Informations générales
SectionAntileishmaniasis medicines- Oral > Solid: 10 mg; 50 mg
-
Moxifloxacin Informations générales
SectionAntituberculosis medicines- Oral > Solid: 400 mg tablet; 100 mg tablet (dispersible)
- Oral > Solid: 400 mg tablet
-
Nevirapine Informations générales
SectionAntiretrovirals > Non-nucleoside reverse transcriptase inhibitors- Oral > Liquid: 50 mg per 5 mL oral solution
- Oral > Solid: 200 mg tablet; 50 mg tablet (dispersible)
-
Niclosamide Informations générales
SectionIntestinal anthelminthics- Oral > Solid: 500 mg tablet (chewable)
-
Nifurtimox Informations générales
SectionMedicines for the treatment of 2nd stage African trypanosomiasis- Oral > Solid > tablet: 120 mg (scored); 30 mg (scored)
IndicationsSectionAmerican trypanosomiasis- Oral > Solid > tablet: 30 mg (scored); 120 mg (scored)
Indications -
Nystatin Informations générales
SectionAntifungal medicines- Oral > Liquid: 100000 IU per mL
- Local > Topical > Other: 100000 IU pessary
- Oral > Solid > dosage form: 500000 IU
- Oral > Solid > lozenge: 100000 IU
Indications -
Oseltamivir Informations générales
SectionOther antivirals- Oral > Solid: 30 mg capsule (as phosphate); 45 mg capsule (as phosphate); 75 mg capsule (as phosphate)
-
Oxamniquine Informations générales
SectionAntischistosomals and other antitrematode medicines- Oral > Liquid: 250 mg per 5 mL
- Oral > Solid: 250 mg capsule
Indications -
P-aminosalicylate sodium Informations générales
SectionAntituberculosis medicines- Oral > Liquid: 5.52 g in sachet (equivalent to 4 g p-aminosalicylic acid)
Indications -
Paromomycin Informations générales
SectionAntileishmaniasis medicines- Parenteral > General injections > IM: 750 mg paromomycin base (as sulfate)
Indications -
Pentamidine Informations générales
SectionAntipneumocystosis and antitoxoplasmosis medicines- Oral > Solid: 200 mg tablet; 300 mg tablet
IndicationsSectionMedicines for the treatment of 1st stage African trypanosomiasis- Parenteral > General injections > IM: 300 mg in vial (as isetionate) powder for injection
Indications -
Phenoxymethylpenicillin Informations générales
SectionAccess group antibiotics- Oral > Liquid: 250 mg per 5 mL (as potassium salt) powder for oral liquid
- Oral > Solid: 250 mg (as potassium salt); 500 mg (as potassium salt)
-
Piperacillin + tazobactam Informations générales
SectionWatch group antibiotics- Parenteral > General injections > IV: 2 g (as sodium salt) + 250 mg (as sodium salt) powder for injection; 4 g (as sodium salt) + 500 mg (as sodium salt) powder for injection
-
Plazomicin Informations générales
SectionReserve group antibiotics- Parenteral > General injections > IV: 500 mg per 10 mL (Injection)
-
Potassium iodide Informations générales
SectionAntifungal medicines- Local > Topical > Solution: Saturated solution
Indications -
Praziquantel Informations générales
SectionAntischistosomals and other antitrematode medicines- Oral > Solid > tablet: 600 mg (scored); 500 mg; 150 mg
IndicationsSectionIntestinal anthelminthics- Oral > Solid > tablet: 600 mg (scored); 500 mg; 150 mg
SectionCysticidal medicines- Oral > Solid > tablet: 600 mg (scored); 500 mg; 150 mg
Indications -
Pretomanid Informations générales
SectionAntituberculosis medicines- Oral > Solid > tablet: 200 mg
Indications -
Primaquine Informations générales
SectionAntimalarial medicines > For curative treatment- Oral > Solid: 7.5 mg tablet (as phosphate); 15 mg tablet (as phosphate)
-
Procaine benzylpenicillin Informations générales
SectionAccess group antibiotics- Parenteral > General injections > IM: 1 g in vial (=1 million IU) powder for injection; 3 g in vial (=3 million IU) powder for injection
-
Proguanil Informations générales
SectionAntimalarial medicines > For chemoprevention- Oral > Solid: 100 mg tablet (hydrochloride)
Indications -
Protionamide Informations générales
SectionAntituberculosis medicinesIndicationsTherapeutic equivalent to ethionamide pour Multi-drug resistant Mycobacterium tuberculosis -
Pyrantel Informations générales
SectionIntestinal anthelminthics- Oral > Solid > tablet: 250 mg (chewable) (as embonate or pamoate)
Indications -
Pyrazinamide Informations générales
SectionAntituberculosis medicines- Oral > Solid: 400 mg; 150 mg tablet (dispersible); 500 mg
Indications -
Pyrimethamine Informations générales
SectionAntipneumocystosis and antitoxoplasmosis medicines- Oral > Solid: 25 mg
Indications -
Quinine Informations générales
SectionAntimalarial medicines > For curative treatment- Parenteral > General injections > IV: 300 mg per mL in 2 mL ampoule (quinine hydrochloride)
- Oral > Solid: 300 mg (quinine sulfate or quinine bisulfate)
Indications -
Raltegravir Informations générales
SectionAntiretrovirals > Integrase inhibitors- Oral > Liquid: 100 mg granules for oral suspension
- Oral > Solid: 400 mg tablet; 25 mg tablet (chewable)
-
Ravidasvir Informations générales
SectionMedicines for hepatitis C > Pangenotypic direct-acting antiviral combinations- Oral > Solid > tablet: 200 mg
Indications -
Ribavirin Informations générales
SectionOther antivirals- Parenteral > General injections > IV: 1000 mg per 10 mL phosphate buffer solution; 800 mg per 10 mL phosphate buffer solution
- Oral > Solid: 200 mg; 400 mg; 600 mg
SectionMedicines for hepatitis C > Other antivirals for hepatitis C- Parenteral > General injections > IV: 1000 mg per 10 mL phosphate buffer solution; 800 mg per 10 mL phosphate buffer solution
- Oral > Solid: 200 mg; 400 mg; 600 mg
Indications -
Rifabutin Informations générales
SectionAntituberculosis medicines- Oral > Solid: 150 mg
Indications -
Rifampicin Informations générales
SectionAntituberculosis medicines- Oral > Liquid: 20 mg per mL
- Oral > Solid: 150 mg; 300 mg
IndicationsSectionAntileprosy medicines- Oral > Liquid: 20 mg per mL
- Oral > Solid: 150 mg; 300 mg
Indications -
Rifapentine Informations générales
SectionAntituberculosis medicines- Oral > Solid: 150 mg tablet; 300 mg tablet
Indications -
Ritonavir Informations générales
SectionAntiretrovirals > Protease inhibitors- Oral > Solid: 25 mg tablet (heat stable); 100 mg tablet (heat stable)
-
Sodium stibogluconate Informations générales
SectionAntileishmaniasis medicines- Parenteral > General injections > unspecified: 100 mg per mL in 30 mL vial
-
Sofosbuvir Informations générales
SectionMedicines for hepatitis C > Pangenotypic direct-acting antiviral combinations- Oral > Solid: 400 mg; 200 mg
Indications -
Sofosbuvir + velpatasvir Informations générales
SectionMedicines for hepatitis C > Pangenotypic direct-acting antiviral combinations- Oral > Solid: 400 mg + 100 mg tablet; 200 mg + 50 mg tablet
Indications -
Spectinomycin Informations générales
SectionAccess group antibiotics- Parenteral > General injections > unspecified: 2 g in vial (as hydrochloride) powder for injection
-
Streptomycin (injection) Informations générales
SectionAntituberculosis medicines- Parenteral > General injections > IV: 1 g powder for injection (as sulfate) as vial
Indications -
Sulfadiazine Informations générales
SectionAntipneumocystosis and antitoxoplasmosis medicines- Oral > Solid: 500 mg
Indications -
Sulfadoxine + pyrimethamine Informations générales
SectionAntimalarial medicines > For curative treatment- Oral > Solid: 500 mg + 25 mg tablet
SectionAntimalarial medicines > For chemoprevention- Oral > Solid: 500 mg + 25 mg tablet
- Oral > Solid: 250 mg + 12.5 mg tablet
Indications -
Sulfamethoxazole + trimethoprim Informations générales
SectionAntipneumocystosis and antitoxoplasmosis medicines- Parenteral > General injections > IV: 80 mg + 16 mg per mL in 5 mL ampoule; 80 mg + 16 mg per mL in 10 mL ampoule
- Oral > Liquid: 200 mg + 40 mg per 5 mL oral liquid
- Oral > Solid: 100 mg + 20 mg tablet; 400 mg + 80 mg tablet; 800 mg + 160 mg tablet
- Oral > Solid > dispersible tablet: 100 mg + 20 mg
Indications -
Suramin sodium Informations générales
SectionMedicines for the treatment of 1st stage African trypanosomiasis- Parenteral > General injections > IV: 1 g in vial
Indications -
Tenofovir disoproxil fumarate Informations générales
SectionAntiretrovirals > Nucleoside/Nucleotide reverse transcriptase inhibitors- Oral > Solid: 300 mg tablet (equivalent to 245 mg tenofovir disoproxil)
SectionMedicines for hepatitis B > Nucleoside/Nucleotide reverse transcriptase inhibitors- Oral > Solid: 300 mg tablet (equivalent to 245 mg tenofovir disoproxil)
Indications -
Terizidone Informations générales
SectionAntituberculosis medicinesIndicationsTherapeutic equivalent to cycloserine pour Multi-drug resistant Mycobacterium tuberculosis -
Tinidazole Informations générales
SectionAntiamoebic and antigiardiasis medicinesIndicationsTherapeutic equivalent to metronidazole pour Amoebiasis -
Triclabendazole Informations générales
SectionAntischistosomals and other antitrematode medicines- Oral > Solid > tablet: 250 mg (scored)
Indications -
Trimethoprim Informations générales
SectionAccess group antibiotics- Oral > Liquid: 50 mg per mL
- Oral > Solid: 100 mg; 200 mg
-
Valaciclovir Informations générales
-
Valganciclovir Informations générales
SectionOther antivirals- Oral > Liquid: 50 mg per mL powder for oral solution
- Oral > Solid: 450 mg Tablet
Indications -
Vancomycin Informations générales
SectionWatch group antibiotics- Parenteral > General injections > IV: 250 mg in vial (as hydrochloride) powder for injection
IndicationsPremier choix
co-prescrite avec ceftazidime Endophthalmitis co-prescrite avec ceftriaxone Endophthalmitis -
Voriconazole Informations générales
SectionAntifungal medicines- Parenteral > General injections > IV: 200 mg in vial powder for injection
- Oral > Liquid: 40 mg per mL powder for oral liquid
- Oral > Solid: 50 mg tablet; 200 mg tablet
-
Zidovudine Informations générales
SectionAntiretrovirals > Nucleoside/Nucleotide reverse transcriptase inhibitors- Parenteral > General injections > IV: 10 mg per mL in 20 mL vial solution for IV infusion injection
- Oral > Liquid: 50 mg per 5 mL
- Oral > Solid: 250 mg capsule; 300 mg tablet